Nextage Therapeutics Ltd (TLV:NXTG)

Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
0.6770
0.00 (0.00%)
At close: May 4, 2026
Market Cap22.81M +6.8%
Revenue (ttm)243.00K -89.1%
Net Income2.84M
EPS0.16
Shares Out33.70M
PE Ratio4.22
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume249,357
Average Volume30,039
Open0.4500
Previous Closen/a
Day's Rangen/a
52-Week Range0.0620 - 1.0700
Beta0.17
RSI55.89
Earnings DateMay 29, 2026

About Nextage Therapeutics

Nextage Therapeutics Ltd, a pharmaceutical company, develops cannabinoid-based products in Israel and internationally. The company was incorporated in 1982 and is based in Ness Ziona, Israel. [Read more]

Sector Healthcare
Founded 1982
Employees 31
Stock Exchange Tel Aviv Stock Exchange
Ticker Symbol NXTG
Full Company Profile

Financial Performance

In 2024, Nextage Therapeutics's revenue was 413,000, a decrease of -52.85% compared to the previous year's 876,000. Losses were -3.28 million, -15.36% less than in 2023.

Financial Statements